Severe Asthma, MepolizumaB and Affect: SAMBA Study
| Заболевание | Severe Eosinophilic Asthma, Psychological Distress, Anxiety, Depression |
|---|---|
| Фаза | Не применимо |
| Спонсор | University Hospital Southampton NHS Foundation Trust |
| Статус | Завершено |
| Участники | 120 участн. |
| Вмешательство | no study intervention. Patients receive standard clinical care |
| Дата начала | 9.09.2021 |
| Дата завершения | 26.03.2025 |
| Публикация результатов | 13.07.2026 |
Кратко
This is a real-life pragmatic non-randomised study to explore the impact of mepolizumab on the emotional and affective outcomes of patients with severe eosinophilic asthma and their partners. It will be conducted in two quantitative stages (Phases 1 and 2) with an additional third qualitative component (Phase 3).
Change in Emotional Composition (Using the Geneva Emotions Wheel)
| Patients With Severe Eosinophilic Asthma Phase 2 | 0.9 score |
|---|---|
| Partners of Patients With Severe Eosinophilic Asthma Phase 2 | 0.1 score |
| Patients With Severe Eosinophilic Asthma Phase 2 | 0.7 score |
| Partners of Patients With Severe Eosinophilic Asthma Phase 2 | 0.0 score |
| Patients With Severe Eosinophilic Asthma Phase 2 | 0.0 score |
| Partners of Patients With Severe Eosinophilic Asthma Phase 2 | 0.2 score |
Открыть в BENITIONS Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
- CBT+ for Depression — University of Wisconsin, Madison
- Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neu — Stanford University
- Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for — Levomecor Inc.
- A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major De — Levomecor Inc.
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders — Massachusetts General Hospital
- Individualized Functional Connectivity Targeting in aiTBS for Depression — Brigham and Women's Hospital